Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB2 known ✓ | P30411 | 2/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30679254 | 0.98 | DNM1 (0.44) | DNM1BDKRB2CA1CA2OPRM1 | |
| Acetic Acid SCHEMBL1685237 | 0.85 | CA1 (0.40) | DNM1CA1CA2 | |
| Phenol SCHEMBL10556722 | 0.79 | ALDH1A1 (0.34) | DNM1BDKRB2CA2 | |
| SCHEMBL13864439 | 0.78 | — | — | |
| SCHEMBL2778416 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL15756110 | 0.71 | DNM1 (0.46) | DNM1BDKRB2OPRM1 | |
| SCHEMBL27469659 | 0.71 | CA1 (0.31) | DNM1CA1CA2OPRM1 | |
| Hydrochloric Acid SCHEMBL23198627 | 0.71 | DNM1 (0.75) | DNM1BDKRB2CA1CA2OPRM1 | |
| Hydrochloric Acid SCHEMBL124627 | 0.71 | DNM1 (0.75) | DNM1BDKRB2CA1CA2OPRM1 | |
| SCHEMBL7797806 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11859074-B2 | Curable fluoroelastomer composition | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-01-02 | — | — | US | claimed |
| US-20210292533-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2021-09-23 | — | — | US | claimed |
| US-20210189111-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2021-06-24 | — | — | US | claimed |
| EP-3807355-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M Innovative Properties Company (US) | 2021-04-21 | — | — | EP | claimed |
| EP-3775019-A1 | BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS | 3M Innovative Properties Company (US) | 2021-02-17 | — | — | EP | claimed |
| EP-3755744-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M Innovative Properties Company (US) | 2020-12-30 | — | — | EP | claimed |
| EP-3755739-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M Innovative Properties Company (US) | 2020-12-30 | — | — | EP | claimed |
| EP-3755745-A1 | BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS | 3M Innovative Properties Company (US) | 2020-12-30 | — | — | EP | claimed |
| US-20200369867-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2020-11-26 | — | — | US | claimed |
| WO-2019197915-A1 | BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-10-17 | — | — | WO | claimed |
| WO-2003095535-A1 | COMPOSITION FOR IMPROVING ADHESION OF BASE-RESISTANT FLUOROELASTOMERS TO METAL, CERAMIC OR GLASS SUBSTRATES | DUPONT DOW ELASTOMERS L.L.C. (US) | 2003-11-20 | — | — | WO | claimed |
| US-6566455-B2 | Delayed curing, scorching safety | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-20 | — | — | US | claimed |
| US-6562911-B2 | Mixing fluoro polymer or blend, each containing interpolymerized units derived from fluorine(s) containing ethylenically unsaturated monomers, an organo onium compound, alkyl or aryl oxalate blocked compound as crosslinker, curing | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-13 | — | — | US | claimed |
| EP-1235875-A1 | FLUOROPOLYMER COMPOSITION WITH ORGANO-ONIUM AND BLOCKED OXALATE COMPOUNDS | 3M Innovative Properties Company (US) | 2002-09-04 | — | — | EP | claimed |
| US-20020099237-A1 | Fluoropolymer composition with organo-onium and blocked oxalate and carbonate compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2002-07-25 | — | — | US | claimed |
| US-20020091282-A1 | Fluoropolymer composition with organo-onium and blocked oxalate compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2002-07-11 | — | — | US | claimed |
| WO-2001038435-A1 | FLUOROPOLYMER COMPOSITIONS CONTAINING ORGANO-ONIUM AND BLOCKED SILYLETHER COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-05-31 | — | — | WO | claimed |
| WO-2001027195-A1 | FLUOROPOLYMER COMPOSITION WITH ORGANO-ONIUM AND BLOCKED OXALATE COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-04-19 | — | — | WO | claimed |
| US-5371143-A | Polymer blend composition of fluorinated elastomers, thermoplastic polymers and thermoplastics elastomers | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-12-06 | — | — | US | claimed |
| US-4882390-A | AND POLYHYDROXY COMPOUND | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-11-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091282-A1 | Fluoropolymer composition with organo-onium and blocked oxalate compounds | PNPO, PDXK, PFAS | BDKRB2 3756/4885DNM1 1566/4885CA1 256/4885 |
| US-20020099237-A1 | Fluoropolymer composition with organo-onium and blocked oxalate and carbonate compounds | PNPO, CALCOCO2, CA4 | BDKRB2 3601/4885DNM1 2244/4885CA1 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.